Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Statin Use Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 32 Clinics in the ThedaCare health system


The results below represent the care of 3,902 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
THEDACARE BEHAVIORAL HEALTH - MIDWAY

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NEW LONDON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NORTH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - OSHKOSH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - SHAWANO

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - TCA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - WAUPACA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS - ENDOCRINOLOGY NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS BLACK CREEK

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS CLINTONVILLE
N=130
95.38 %
View Historical Data
THEDACARE PHYSICIANS DARBOY
N=152
92.76 %
View Historical Data
THEDACARE PHYSICIANS HILBERT

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS INTERNAL MEDICINE - KNAUS

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS INTERNAL MEDICINE APPLETON
N=397
93.95 %
View Historical Data
THEDACARE PHYSICIANS INTERNAL MEDICINE NEENAH
N=222
90.09 %
View Historical Data
THEDACARE PHYSICIANS IOLA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS KIMBERLY
N=168
91.67 %
View Historical Data
THEDACARE PHYSICIANS MANAWA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS MENASHA
N=258
97.29 %
View Historical Data
THEDACARE PHYSICIANS NEENAH
N=393
96.18 %
THEDACARE PHYSICIANS NEW LONDON
N=414
93.72 %
View Historical Data
THEDACARE PHYSICIANS NORTH
N=450
93.11 %
View Historical Data
THEDACARE PHYSICIANS OSHKOSH
N=156
90.38 %
View Historical Data
THEDACARE PHYSICIANS PEDIATRICS APPLETON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS PEDIATRICS NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS SENIOR CARE SPECIALISTS

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS SHAWANO
N=497
93.56 %
View Historical Data
THEDACARE PHYSICIANS TIGERTON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS WAUPACA
N=493
94.52 %
View Historical Data
THEDACARE PHYSICIANS WEST
N=172
90.70 %
View Historical Data
THEDACARE PHYSICIANS WEYAUWEGA

The number of patients or providers is too small for
purposes of reliably reporting performance

The American College of Cardiology (ACC) and the American Heart Association (AHA) recommends that high-intensity statin therapy should be initiated or continued as first-line therapy in women and men less than or equal to 75 years of age who have clinical atherosclerotic cardiovascular disease, unless contraindicated.

In November 2013, the ACC and AHA Task Force on Practice Guidelines released updated guidance for the treatment of blood cholesterol. The new recommendations remove treatment targets for LDL-C for the primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and recommend high or moderate intensity statin therapy based on patient risk factors. Four major statin benefit groups were identified and iIndividuals with ASCVD are one of the identified groups.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.